210 related articles for article (PubMed ID: 14597628)
1. Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding.
Loland CJ; Grånäs C; Javitch JA; Gether U
J Biol Chem; 2004 Jan; 279(5):3228-38. PubMed ID: 14597628
[TBL] [Abstract][Full Text] [Related]
2. Evidence for distinct sodium-, dopamine-, and cocaine-dependent conformational changes in transmembrane segments 7 and 8 of the dopamine transporter.
Norregaard L; Loland CJ; Gether U
J Biol Chem; 2003 Aug; 278(33):30587-96. PubMed ID: 12773538
[TBL] [Abstract][Full Text] [Related]
3. Aspartate 345 of the dopamine transporter is critical for conformational changes in substrate translocation and cocaine binding.
Chen N; Rickey J; Berfield JL; Reith ME
J Biol Chem; 2004 Feb; 279(7):5508-19. PubMed ID: 14660644
[TBL] [Abstract][Full Text] [Related]
4. Generation of an activating Zn(2+) switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle.
Loland CJ; Norregaard L; Litman T; Gether U
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1683-8. PubMed ID: 11818545
[TBL] [Abstract][Full Text] [Related]
5. Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors.
Loland CJ; Desai RI; Zou MF; Cao J; Grundt P; Gerstbrein K; Sitte HH; Newman AH; Katz JL; Gether U
Mol Pharmacol; 2008 Mar; 73(3):813-23. PubMed ID: 17978168
[TBL] [Abstract][Full Text] [Related]
6. The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter.
Reith ME; Berfield JL; Wang LC; Ferrer JV; Javitch JA
J Biol Chem; 2001 Aug; 276(31):29012-8. PubMed ID: 11395483
[TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains.
Lin Z; Wang W; Uhl GR
Mol Pharmacol; 2000 Dec; 58(6):1581-92. PubMed ID: 11093799
[TBL] [Abstract][Full Text] [Related]
8. A pincer-like configuration of TM2 in the human dopamine transporter is responsible for indirect effects on cocaine binding.
Sen N; Shi L; Beuming T; Weinstein H; Javitch JA
Neuropharmacology; 2005 Nov; 49(6):780-90. PubMed ID: 16216288
[TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter transmembrane domain polar mutants: DeltaG and DeltaDeltaG values implicate regions important for transporter functions.
Itokawa M; Lin Z; Cai NS; Wu C; Kitayama S; Wang JB; Uhl GR
Mol Pharmacol; 2000 Jun; 57(6):1093-103. PubMed ID: 10825379
[TBL] [Abstract][Full Text] [Related]
10. Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter.
Chen N; Ferrer JV; Javitch JA; Justice JB
J Biol Chem; 2000 Jan; 275(3):1608-14. PubMed ID: 10636852
[TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.
Lin Z; Itokawa M; Uhl GR
FASEB J; 2000 Apr; 14(5):715-28. PubMed ID: 10744628
[TBL] [Abstract][Full Text] [Related]
12. Permeation and gating residues in serotonin transporter.
Chen JG; Rudnick G
Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1044-9. PubMed ID: 10655481
[TBL] [Abstract][Full Text] [Related]
13. The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding.
Chen JG; Sachpatzidis A; Rudnick G
J Biol Chem; 1997 Nov; 272(45):28321-7. PubMed ID: 9353288
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
[TBL] [Abstract][Full Text] [Related]
15. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.
Loland CJ; Mereu M; Okunola OM; Cao J; Prisinzano TE; Mazier S; Kopajtic T; Shi L; Katz JL; Tanda G; Newman AH
Biol Psychiatry; 2012 Sep; 72(5):405-13. PubMed ID: 22537794
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
17. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
Chen R; Han DD; Gu HH
J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
[TBL] [Abstract][Full Text] [Related]
18. Importance of valine at position 152 for the substrate transport and 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane binding of dopamine transporter.
Lee SH; Chang MY; Lee KH; Park BS; Lee YS; Chin HR; Lee YS
Mol Pharmacol; 2000 May; 57(5):883-9. PubMed ID: 10779370
[TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.
Kitayama S; Shimada S; Xu H; Markham L; Donovan DM; Uhl GR
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7782-5. PubMed ID: 1502198
[TBL] [Abstract][Full Text] [Related]
20. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis.
Chen N; Vaughan RA; Reith ME
J Neurochem; 2001 May; 77(4):1116-27. PubMed ID: 11359877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
